Cargando…
Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels
BACKGROUND: Carcinoembryonic antigen (CEA) is a cancer biomarker used in colorectal cancer (CRC) for tumor screening and outcome prediction. However it is still lack of sensitivity and specificity in general population. The present study aimed to investigate the clinical significance of CEA in patie...
Autores principales: | Zhang, Chiming, Zheng, Wenqian, Lv, Yiming, Shan, Lina, Xu, Dengyong, Pan, Yangtao, Zhu, Hongbo, Qi, Haiou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798572/ https://www.ncbi.nlm.nih.gov/pubmed/35117164 http://dx.doi.org/10.21037/tcr.2019.11.27 |
Ejemplares similares
-
Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973) -
The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
por: Xie, Hai-Lun, et al.
Publicado: (2019) -
Carcinoembryonic antigen (CEA) plasma levels in Michigan and Wisconsin dairy farmers.
por: Anderson, H A, et al.
Publicado: (1978) -
First British standard for carcinoembryonic antigen (CEA).
por: Laurence, D. J., et al.
Publicado: (1975) -
Immunochemical studies of carcinoembryonic antigen (CEA) variants.
por: Ichiki, A. T., et al.
Publicado: (1976)